News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,730 Results
Type
Article (8016)
Company Profile (141)
Press Release (479573)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238206)
Policy (17900)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (495)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33157)
ALS (118)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (315)
Approvals (10467)
Artificial intelligence (355)
ASCO (160)
Autoimmune disease (234)
Automation (33)
Bankruptcy (263)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (32)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (13)
Bladder cancer (143)
Brain cancer (35)
Breast cancer (536)
Cancer (3947)
Cardiovascular disease (236)
Career advice (245)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (28)
Celiac Disease (3)
Cell therapy (506)
Cervical cancer (36)
Clinical research (48365)
Collaboration (1353)
Commercialization (21)
Compensation (1605)
Complete response letters (36)
COVID-19 (769)
CRISPR (68)
C-suite (848)
Cystic fibrosis (89)
Data (6253)
Denatured (4)
Depression (108)
Dermatology (95)
Diabetes (377)
Diagnostics (4253)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (168)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73900)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88603)
Executive appointments (734)
Eye disease (3)
FDA (12654)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (990)
Gene editing (132)
Generative AI (13)
Gene therapy (350)
GLP-1 (309)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9384)
Hematology (94)
HIV (56)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (75)
Immunology and inflammation (113)
Immuno-oncology (68)
Indications (177)
Infectious disease (970)
Inflammatory bowel disease (141)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (41)
IPO (12396)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (69)
Layoffs (59)
Legal (5195)
Licensing (43)
Liver cancer (46)
Longevity (25)
Lung cancer (568)
Lung diease (8)
Lymphoma (266)
Machine learning (29)
Management (3)
Manufacturing (614)
Marketing (19)
MASH (121)
Medical affairs (2)
Medical device (8708)
Medtech (8886)
Mergers & acquisitions (14449)
Metabolic disorders (763)
mRNA (70)
Multiple sclerosis (114)
Multispecific (2)
NASH (4)
Netherlands (2)
Neurodegenerative disease (240)
Neuropsychiatric disorders (40)
Neuroscience (1929)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (240)
Opinion (10)
Ovarian cancer (177)
Pain (188)
Pancreatic cancer (227)
Parkinson's disease (217)
Partnered (12)
Patents (522)
Patient advocacy (2)
Patient recruitment (548)
Patient selection (36)
Peanut (33)
People (41504)
Peptides (14)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15602)
Phase 2 (21608)
Phase 3 (14587)
Pipeline (8315)
Policy (18)
Postmarket research (1570)
Preclinical (6589)
Press Release (34)
Prostate cancer (202)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (620)
Real estate (3024)
Recruiting (6)
Regenerative medicine (11)
Regulatory (15164)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (46)
RNA editing (9)
RSV (49)
Schizophrenia (109)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2021)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (348)
Venture capital (17)
Weight loss (77)
Wet AMD (3)
Women's health (97)
Date
Today (83)
Last 7 days (374)
Last 30 days (1611)
Last 365 days (19178)
2026 (15351)
2025 (19251)
2024 (22987)
2023 (26539)
2022 (34587)
2021 (37169)
2020 (33470)
2019 (23259)
2018 (17474)
2017 (18765)
2016 (17918)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (318)
Arkansas (12)
Asia (18039)
Australia (2116)
California (12818)
Canada (3346)
China (568)
Colorado (526)
Connecticut (445)
Delaware (223)
Europe (24800)
Florida (1926)
Georgia (405)
Hawaii (3)
Idaho (46)
Illinois (764)
India (58)
Indiana (331)
Iowa (18)
Japan (450)
Kansas (104)
Kentucky (33)
Louisiana (28)
Maine (27)
Maryland (1269)
Massachusetts (8381)
Michigan (321)
Minnesota (590)
Mississippi (4)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (132)
New Hampshire (60)
New Jersey (2819)
New Mexico (12)
New York (3004)
North Carolina (1361)
North Dakota (4)
Northern California (6489)
Ohio (303)
Oklahoma (15)
Oregon (17)
Pennsylvania (2387)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5338)
Tennessee (128)
Texas (2115)
United States (41534)
Utah (391)
Vermont (1)
Virginia (165)
Washington D.C. (39)
Washington State (984)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,730 Results for "oxthera inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Drug Development
OxThera reports results from Phase 3 ePHex study with Oxabact in primary hyperoxaluria patients with maintained kidney function
OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria, announces completion of its pivotal Phase 3 study and reports top line results.
June 11, 2021
·
4 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Policy
OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues
OxThera AB today announced a granted US patent on Oxalobacter formigenes secretagogues.
November 15, 2018
·
2 min read
Drug Development
OxThera Announces Completion of Recruitment in Phase 3 ePHex Study With Oxabact® in Patients With Primary Hyperoxaluria
OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria, announced that it has completed enrollment in its Oxabact ePHex phase III study.
April 6, 2020
·
3 min read
Press Releases
Medtronic Completes Separation of MiniMed Group, Inc.
October 15, 2026
·
3 min read
Business
Hugo Petit Appointed CFO of OxThera
OxThera AB today announced the appointment of Hugo Petit as its new Chief Financial Officer. Mr Petit previously served as the Chief Financial Officer of MedCap AB.
September 7, 2018
·
1 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
October 22, 2026
·
18 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
1 of 48,773
Next
